A Two-Phase Translational Framework for Personalized Ozone Therapy: From Baseline Clinical Redox Screening to Individualized Ex Vivo Concentration Selection

Ioannis Iliakis, Emmanouil Iliakis, Demitrios Vynios

Open source

DOI
10.3390/jpm16100510
Published
2026-09-29
Container
Journal of Personalized Medicine
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jpm16100510,
  title = {A Two-Phase Translational Framework for Personalized Ozone Therapy: From Baseline Clinical Redox Screening to Individualized Ex Vivo Concentration Selection},
  author = {Ioannis Iliakis and Emmanouil Iliakis and Demitrios Vynios},
  year = {2026},
  journal = {Journal of Personalized Medicine},
  doi = {10.3390/jpm16100510},
  url = {https://doi.org/10.3390/jpm16100510}
}

RIS

TY  - JOUR
TI  - A Two-Phase Translational Framework for Personalized Ozone Therapy: From Baseline Clinical Redox Screening to Individualized Ex Vivo Concentration Selection
AU  - Ioannis Iliakis
AU  - Emmanouil Iliakis
AU  - Demitrios Vynios
PY  - 2026
JO  - Journal of Personalized Medicine
DO  - 10.3390/jpm16100510
UR  - https://doi.org/10.3390/jpm16100510
ER  - 

APA

Iliakis, I., Iliakis, E., & Vynios, D. (2026). A Two-Phase Translational Framework for Personalized Ozone Therapy: From Baseline Clinical Redox Screening to Individualized Ex Vivo Concentration Selection. Journal of Personalized Medicine. https://doi.org/10.3390/jpm16100510

Source records